BALDR: A Web-based platform for informed comparison and prioritization of biomarker candidates for type 2 diabetes mellitus
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
BALDR : A Web-based platform for informed comparison and prioritization of biomarker candidates for type 2 diabetes mellitus. / Lundgaard, Agnete T.; Burdet, Frédéric; Siggaard, Troels; Westergaard, David; Vagiaki, Danai; Cantwell, Lisa; Röder, Timo; Vistisen, Dorte; Sparsø, Thomas; Giordano, Giuseppe N.; Ibberson, Mark; Banasik, Karina; Brunak, Søren.
I: PLOS Computational Biology, Bind 19, Nr. 8, e1011403, 2023.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - BALDR
T2 - A Web-based platform for informed comparison and prioritization of biomarker candidates for type 2 diabetes mellitus
AU - Lundgaard, Agnete T.
AU - Burdet, Frédéric
AU - Siggaard, Troels
AU - Westergaard, David
AU - Vagiaki, Danai
AU - Cantwell, Lisa
AU - Röder, Timo
AU - Vistisen, Dorte
AU - Sparsø, Thomas
AU - Giordano, Giuseppe N.
AU - Ibberson, Mark
AU - Banasik, Karina
AU - Brunak, Søren
N1 - Publisher Copyright: © 2023 Lundgaard et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
PY - 2023
Y1 - 2023
N2 - Novel biomarkers are key to addressing the ongoing pandemic of type 2 diabetes mellitus. While new technologies have improved the potential of identifying such biomarkers, at the same time there is an increasing need for informed prioritization to ensure efficient downstream verification. We have built BALDR, an automated pipeline for biomarker comparison and prioritization in the context of diabetes. BALDR includes protein, gene, and disease data from major public repositories, text-mining data, and human and mouse experimental data from the IMI2 RHAPSODY consortium. These data are provided as easy-to-read figures and tables enabling direct comparison of up to 20 biomarker candidates for diabetes through the public website https://baldr.cpr.ku.dk.
AB - Novel biomarkers are key to addressing the ongoing pandemic of type 2 diabetes mellitus. While new technologies have improved the potential of identifying such biomarkers, at the same time there is an increasing need for informed prioritization to ensure efficient downstream verification. We have built BALDR, an automated pipeline for biomarker comparison and prioritization in the context of diabetes. BALDR includes protein, gene, and disease data from major public repositories, text-mining data, and human and mouse experimental data from the IMI2 RHAPSODY consortium. These data are provided as easy-to-read figures and tables enabling direct comparison of up to 20 biomarker candidates for diabetes through the public website https://baldr.cpr.ku.dk.
U2 - 10.1371/journal.pcbi.1011403
DO - 10.1371/journal.pcbi.1011403
M3 - Journal article
C2 - 37590326
AN - SCOPUS:85168773432
VL - 19
JO - P L o S Computational Biology (Online)
JF - P L o S Computational Biology (Online)
SN - 1553-734X
IS - 8
M1 - e1011403
ER -
ID: 366766672